T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: T-DM1|DRUG: Lapatinib|DRUG: Abraxane
Sponsor: Jenny C. Chang, MD
Collaborators: The Methodist Hospital Research Institute